References
- Midtvedt T. Microflora-associated characteristics (MACs) and germfree animal characteristics (GACs) in man and animal. Microecol Ther 1985; 15: 295–302.
- Bartlett JG. Antibiotic-associated diarrhoea. Clin Infect Dis 1992; 15: 573–81.
- Vogel LC. Antibiotic-induced diarrhoea. Orthop Nurs 1995; 14: 38–41.
- Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330: 257–62.
- Bartlett JG. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 1994; 18 Suppl 4: S265–72.
- Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G. Prevention of antibiotic-associated diarrhoea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96: 981–8.
- Bergogne-Bérézin E. Ecologic impact of antibiotics. Role of substitution microorganisms to control antibiotic-related diarrhoea and colitis. Presse Med 1995; 24: 145–56.
- Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL. Treatment of recurrrent Clostridium difficile colitis with Lactobacillus GG. J Ped Gastroenterol Nutr 1995; 21: 224–6.
- Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; 2: 1519.
- Bartlett JG. Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas. Eur J Gastroenterol Hepatol 1996; 8: 1054–61.
- Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; 1: 1156–60.
- Rolfe RD. Probiotics: prospects for use in Clostridium difficile-associated intestinal disease. In: Fuller R, Heidt PJ, Rusch V, van der Waaij D, editors. Old Herborn University Seminar Monograph 8. Herborn, Germany: Institute for Microbiology and Biochemistry; 1995. p. 47–66.
- Orrhage K, Brismar B, Nord CE. Effect of supplements with Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin. Microb Ecol Health Dis 1994; 7: 17–25.
- Bowden TA, Mansberger A, Lykins L. Pseudomembranous enterocolitis: mechanism of restoring floral homeostasis. Am Surg 1981; 47: 178–83.
- Schwan A, Sjölin S, Trottestam U, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis 1984; 16: 211–5.
- Schwan A, Sjölin S, Trottestam U, Aronson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983; 2: 845.
- Midtvedt T. In vivo models for short-chain fatty acid production. In: Binder HJ, Cummings J, Soergel K, editors. Short-chain fatty acids. Falck symposium 73. London: Kluwer; 1993. p. 61–8.
- Midtvedt T. Influence of antibiotics on biochemical intestinal microflora-associated characteristics in man and animals. In: Gillissen G, Opferkuch W, Peters G, Pulverer G, editors. The influence of antibiotics on the host-parasite relationship. III. Berlin: Springer-Verlag; 1989. p. 209–15.
- Mortensen PB, Clausen MR. Antibiotic-associated diarrhoea. In: Binder HJ, Cummings J, Soergel K, editors. Short-chain fatty acids. Falck symposium 73. London: Kluwer; 1993. p. 240–7.
- Midtvedt T, Carlstedt-Duke B, Høverstad T, Lingaas E, Norin E, Saxerholt H, et al. Influence of peroral antibiotics upon the biotransformatory activity of the intestinal microflora in healthy subjects. Eur J Clin Invest 1986; 16: 11–7.
- Hoverstad T, Carlstedt-Duke B, Lingaas E, Midtvedt T, Norin KE, Saxerholt H, et al. Influence of ampicillin, clindamycin, and metronidazole on faecal excretion of short-chain fatty acids in healthy subjects. Scand J Gastroenterol 1986; 21: 621–6.
- Steinbakk M, Lingaas E, Carlstedt-Duke B, Hoverstad T, Midtvedt A-C, Norin KE, et al. Faecal concentration of ten antibiotics and influence on some microflora-associated characteristics (MACs). Microb Ecol Health Dis 1992; 5: 269–76.
- Lund-Tønnesen S, Berstad A, Schreiner A, Midtvedt T. Clostridium difficile-assosiert diare behandlet med homolog feces. Tidsskr Nor Laegeforen 1998; 118: 1027–30.
- Leijonmarck C-E, Bergstrand O, Carlstedt-Duke B, Gustafsson A, Midtvedt A-C, Norin KE, et al. Total parenteral nutrition and the function of the intestinal microflora in Crohn’s disease. Scand J Gastroenterol 1988; 23: 59–64.
- Siigur U, Norin KE, Allgood G, Schlagheck T, Midtvedt T. Concentrations and correlations of faecal short-chain fatty acids and faecal water content in man. Microb Ecol Health Dis 1994; 7: 287–294.
- Zijlstra JB, Beukema J, Wolthers BG, Byrne BM, Groen A, Dankert J. Pretreatment methods prior to gaschromatographic analysis of volatile fatty acids from faecal samples. Clin Chim Acta 1977; 78: 243–50.
- Høverstad T, Fausa O, Bjørneklett A, Bøhmer T. Short-chain fatty acids in the normal human feces. Scand J Gastroenterol 1984; 19: 375–81.
- Siigur U, Tamm E, Torm S, Lutsar I, Salminen S, Midtvedt T. Effect of bacterial infection and administration of a probiotic on faecal short-chain fatty acids. Microb Ecol Health Dis 1996; 9: 271–7.
- Hove H, Tvede M, Mortensen PB. Antibiotic-associated diarrhoea, Clostridium difficile, and short-chain fatty acids. Scand J Gastroenterol 1996; 31: 688–93.
- Høverstad T, Midtvedt T, Bøhmer T. Short-chain fatty acids in intestinal content of germfree mice monocontaminated with Escherichia coli or Clostridium difficile. Scand J Gastroenterol 1985; 20: 373–80.
- Høverstad T, Carlstedt-Duke B, Lingaas E, Norin E, Saxerholt H, Steinbakk M, et al. Influence of oral intake of seven different antibiotics on faecal short-chain fatty acid excretion in healthy subjects. Scand J Gastroenterol 1986; 21: 997–1003.